Improvements in surgical techniques and availability of immunosuppressive options have
led to current successes in the arena of solid organ transplantation. Historically …

Although solid organ transplant results have improved significantly in recent decades, a
pivotal cause of impaired long-term outcome is the development of antibody-mediated …

We report the effectiveness of daratumumab, a human IgGκ monoclonal antibody targeting
CD38 on plasma cells, for therapy-refractory antibody-mediated rejection (AMR) due to …

Antibody‐mediated rejection (AMR) is the commonest cause of failure of a pig graft after
transplantation into an immunosuppressed nonhuman primate (NHP). The incidence of …

The appropriate regulation of T cell activity under inflammatory conditions is crucial for
maintaining immune homeostasis. Salinosporamide A discovered as a self-resistance …

Although acute renal graft rejection rate has declined in the last years, and because an
adequate therapy can improve graft outcome, its therapy remains as one of the most …

Background: Antibody-mediated rejection (ABMR) following kidney transplant is closely
associated with poor prognosis of the recipients. Long-lived plasma cells (LLPCs) produce …

Objectives Antibody-mediated rejection (AMR) is a large obstacle to the long-term survival of
allograft kidneys. It is urgent to find novel strategies for its prevention and treatment …

Simple Summary Multiple myeloma remains an essentially incurable blood cancer. New
patients with multiple myeloma are often treated with induction chemotherapy, stem cell …

Background: Despite major advances in transplant medicine, antibody-mediated rejection
(AMR) continues to have severe clinical implications and adversely affect graft survival …